![]() Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. | NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ![]() Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | |
Founding Date | Founding Date 2006 | Founding Date 2006 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB |
Employees | Employees 743% increase | Employees 91 | Employees 3218% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) 49.7 m |
Financial | |||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) €33.2m (FY, 2022) |
Cost of goods | Cost of goods $4.8m (FY, 2021) | Cost of goods £11.1m (FY, 2025) | Cost of goods €382k (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit £38.2m (FY, 2025) | Gross profit €33.4m (FY, 2022) |
Net income | Net income ($227.4m) (FY, 2021) | Net income £7m (FY, 2025) | Net income (€579k) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 15.2m |
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company